Osteoarthritis, magnetic resonance imaging, and biochemical markers: A one year prospective study

Annals of the Rheumatic Diseases

Volumn 65, Issue 8, 2006, Pages 1050-1054

  Bruyere, Olivier ^a,b   Collette, J ^b   Kothari, M ^c   Zaim, S ^c   White, D ^c   Genant, H ^c   Peterfy, C ^c   Burlet, N ^b   Ethgen, D ^d   Montague, T ^d   Dabrowski, C ^d   Reginster, J Y ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c SYNARC INC   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; GLYCOPROTEIN GP 39; HYALURONIC ACID; OSTEOCALCIN;

ADULT; AGED; ARTICLE; CARTILAGE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEMUR; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; SYNOVIAL FLUID; TIBIA;

AGED; BIOLOGICAL MARKERS; BONE REMODELING; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; HYALURONIC ACID; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOCALCIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SYNOVIAL MEMBRANE;

EID: 33746521768     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.045914     Document Type: Article

References (29)

1. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P. The incidence and natural history of knee osteoarthritis in the elderly. Arthritis Rheum 1995;38:1500-5.
2. Kirwan JR, Elson CJ. Is the progression of osteoarthritis phasic? Evidence and implication. J Rheumatol 2000;27:834-6.
3. Vignon E, Garnero P, Avouac B, Bettica P, Boers M, Delmas P, et al. Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis Cartilage 2001;9:289-93.
4. Garnero P, Rousseau J-C, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 2000;43:953-68.
5. Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, et al. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthritis Cartilage 2004;12:263-8.
6. Peterfy CG, Guermazi A, Zaim S, Tirman PFJ, Miaux Y, White D, et al. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004;12:177-90.
7. Lohmander LS. The role of molecular markers to monitor breakdown and repair. In: Reginster J-Y, Pelletier J-P, Martel-Pelletier JM, Henrotin Y, eds. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag, 1999:296-311.
8. Kellgen JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502.
9. Peterfy CG, van Dijke CF, Janzen DL, Gluer CC, Namba R, Majumdar S, et al. Quantification of articular cartilage in the knee with pulsed saturation transfer subtraction and fat-suppressed MR imaging: optimization and validation. Radiology 1994;192:485-91.
10. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26.
11. Peterson IF, Boegard T, Dahlstrom J, Svensson B, Heinegard D, Saxne. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthritis Cartilage 1998;6:33-9.
12. Vilim V, Vytasek R, Olejorava M, Machacek S, Gatterova J, Prochazka B, et al. Serum cartilage oligometric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage 2001;9:612-18.
13. Pavelka K, Forejtova S, Olejarova J, Senolt L, Spacek P, Braun M, et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 2004;12:277-83.
14. Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, et al. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 2005:105-11.
15. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of knee damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-24.
16. Christgau S, Henrotin Y, Tanko LB, Rovati LC, Collette J, Bruyere O, et al. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulfate. Clin Exp Rheum 2004;22:36-42.
17. Reijman M, Hazes JMW, Bierma-Zeinstra SMA, Koes BW, Christgau S, Christiansen C, et al. A new marker for osteoarthritis. Cross-sectional and longitudinal approach. Arthritis Rheum 2004;50:2471-8.
18. Bruyère O, Collette JH, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, et al. Biochemical markers of bone and cartilage remodelling for the prediction of long-term progression of knee osteoarthritis. J Rheumatol 2003;30:1043-50.
19. Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Osteoarthritis Cartilage 2001;9:203-14.
20. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 1999;7:371-3.
21. Felson DT, Neogi T. Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum 2004;50:341-4.
22. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophytes formation by alendronate in the rat anterior cruciate ligament transaction model. Arthritis Rheum 2004;50:1193-2006.
23. Manicourt DH, Altman RD, Williams JM, Devogelaer JP, Druetz-Van Egeren A, Lenz ME, et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum 1999;42:1159-67.
24. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ-MA, Cushnaghan J, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995;38:760-7.
25. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40:723-7.
26. Petersson IF, Boegard T, Svensson B, Heinegard D, Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998;37:46-50.
27. Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegard D, Dieppe PA. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995;34:306-10.
28. Sugiyama S, Itokazu M, Suzuki Y, Shimizu K. Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 2003;62:27-32.
29. Henrotin Y, Deberg M, Dubuc JE, Quettier E, Christgau S, Reginster JY. Type II collagen peptides for measuring cartilage degradation. Biorheology 2004;41:543-7.